Clarke Barlow
Fortune : 3 733 $ au 31/07/2026
Fortune : 3 733 $ au 31/07/2026
Clarke Colin Barlow is the founder of AMG Acquisition Corp., founded in 2021, serving as Independent Director since 2021.
Current jobs include Non-Executive Director at Neuroscientific Biopharmaceuticals Ltd. since 2023 and Member at Australian Institute of Co. Directors.
Former jobs include Non-Executive Director at Exopharm Ltd. and Non-Executive Director at Entropy Neurodynamics Ltd. in 2024.
Education includes undergraduate studies at The University of Western Australia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AMG ACQUISITION CORP. 11,59 % | 06/05/2025 | 533 340 ( 11,59 % ) | 3 733 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AMG ACQUISITION CORP. | Fondateur | 01/06/2021 |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 17/11/2023 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| EXOPHARM | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd. BiotechnologyHealth Technology Engages in researching and developing pharmaceutical products | Health Technology |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
AMG Acquisition Corp.
AMG Acquisition Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national